Agilent Technologies Inc (A)vsQuest Diagnostics Incorporated (DGX)
A
Agilent Technologies Inc
$111.30
-0.40%
HEALTHCARE · Cap: $31.48B
DGX
Quest Diagnostics Incorporated
$195.26
+0.57%
HEALTHCARE · Cap: $21.72B
Smart Verdict
WallStSmart Research — data-driven comparison
Quest Diagnostics Incorporated generates 56% more annual revenue ($11.04B vs $7.07B). A leads profitability with a 18.3% profit margin vs 9.0%. A appears more attractively valued with a PEG of 1.16. DGX earns a higher WallStSmart Score of 61/100 (C+).
A
Buy61
out of 100
Grade: C+
DGX
Buy61
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-320.3%
Fair Value
$30.67
Current Price
$111.30
$80.63 premium
Margin of Safety
+2.6%
Fair Value
$214.96
Current Price
$195.26
$19.70 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 20 in profit
Strong operational efficiency at 22.9%
Reasonable price relative to book value
Areas to Watch
Grey zone — moderate risk
Weak financial health signals
Earnings declined 3.6%
Expensive relative to growth rate
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on Return on Equity, Operating Margin. Profitability is solid with margins at 18.3% and operating margin at 22.9%. PEG of 1.16 suggests the stock is reasonably priced for its growth.
Bull Case : DGX
The strongest argument for DGX centers on Price/Book.
Bear Case : A
The primary concerns for A are Altman Z-Score, Piotroski F-Score, EPS Growth.
Bear Case : DGX
The primary concerns for DGX are PEG Ratio, Piotroski F-Score.
Key Dynamics to Monitor
A profiles as a mature stock while DGX is a value play — different risk/reward profiles.
A carries more volatility with a beta of 1.31 — expect wider price swings.
DGX is growing revenue faster at 7.1% — sustainability is the question.
DGX generates stronger free cash flow (307M), providing more financial flexibility.
Bottom Line
A scores higher overall (61/100 vs 61/100), backed by strong 18.3% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
Quest Diagnostics Incorporated
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?